Center of Excellence in Integrative Cancer Biology and Genomics Symposium
DCEG Events
May 16, 2017 | 1:30 PM – 4:30 PM
NCI Bethesda Bethesda, MD
Keynote Speaker
Haichuan Hu, Massachusetts General Hospital
Role of the Tumor Stroma in Response to Tyrosine Kinase Inhibitor in NSCLC
Other Speakers
Snehal Gaikwad, Laboratory of Cancer Biology and Genetics, CCR, NCI
Molecular Mechanism of Resistance to Proteasome Inhibitors in Multiple Myeloma
Ruediger Meyer, Genetics Branch, CCR, NCI
Clonal Heterogeneity and Treatment Response in Rectal Cancer
Nityashree Shivaprasad, Genetics Branch, CCR, NCI
FGFR4 Specific Chimeric Antigen Receptor (CAR) T Cell Therapy Against Rhabdomyosarcoma
Thomas Ahearn, Ph.D., M.P.H., Integrative Tumor Epidemiology Branch, DCEG, NCI
A Large-Scale Genetic Association Study of Breast Cancer Subtypes
Visit the NCI Center of Excellence in Integrative Cancer Biology and Genomics website.